Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

SOVALDI

SOFOSBUVIR

Standard Dose
200MG/PACKET
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview SOVALDI is listed in Drugs@FDA under application 212480 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient SOFOSBUVIR Form and strength PELLETS;ORAL - 200MG/PACKET Sponsor GILEAD SCIENCES INC Submission history Latest submission status date: 2024-12-23 00:00:00.

Structured Monograph

Clinical summary

Approval overview SOVALDI is listed in Drugs@FDA under application 212480 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SOFOSBUVIR Form and strength PELLETS;ORAL - 200MG/PACKET Sponsor GILEAD SCIENCES INC Submission history Latest submission status date: 2024-12-23 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
SOVALDI (SOFOSBUVIR) | Drug Monograph | MedicHelpline